Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Histogenex

Histogenex
2001 FOUNDED
PRIVATE STATUS
81-90 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE (Announced)
3 FINANCING ROUNDS
Description

Provider of laboratory services for immune-oncology therapies. The company supports pharmaceutical and biotechnology companies in the process of developing, approving and monitoring new anticancer drugs through the development and implementation of biomarker tests.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Laboratory Services (Healthcare)
Primary Office
  • Sint-Bavostraat 78
  • 2610 Antwerp
  • Belgium

+32 03 000 00 00

Histogenex Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Histogenex‘s full profile, request access.

Request full access to PitchBook

Histogenex Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Invitae Formerly VC-backed San Francisco, CA 000 00000 00000000000 00000
0000000000 0000000 Corporate Backed or Acquired Cambridge, MA 000 00000 00000000000
To view this company’s complete list of competitors, request access »

Histogenex Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Histogenex‘s full profile, request access.

Request full access to PitchBook

Histogenex Executive Team (4)

Name Title Board
Seat
Contact
Info
Dirk Hendriks Ph.D Chief Financial Officer, Director Strategic Business Development & Co- Founder
Kurt Peeters Ph.D Chief Operating Officer
Christopher Ung Chief Business Officer
Mark Kockx Ph.D Chief Executive Officer, Chief Medical Officer and Co-Founder